Soo-youn Moon

Dr. Soo-youn Moon

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2017 in Mycoses
Verified
Journal Article
Closed access
PDF file
HCHyoung Il Choi
Hyoung Il Choi
JAJin An
Jin An
JHJae Joon Hwang
Jae Joon Hwang
SMSoo-youn Moon
Soo-youn Moon
JSJun Seong Son
Jun Seong Son

30 September 2010 in Journal of Infection
Verified
Journal Article
Closed access
MJMi Kyong Joung
Mi Kyong Joung
KKKi Tae Kwon
Ki Tae Kwon
CKCheol-In Kang
Cheol-In Kang
HCHae Suk Cheong
Hae Suk Cheong
JRJi-Young Rhee
Ji-Young Rhee
KPKyong Ran Peck
Kyong Ran Peck

1 January 2015 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
MLMin Hye Lee
Min Hye Lee
JBJongkyu Byun
Jongkyu Byun
MJMyounghwa Jung
Myounghwa Jung
JYJohn Jeongseok Yang
John Jeongseok Yang
KPKi-Ho Park
Ki-Ho Park
MLMi Suk Lee
Mi Suk Lee
Lee MH, et al. Infect Chemother. 2015 Mar;47(1):60-63. https://doi.org/10.3947/ic.2015.47.1.60

Verified
Journal Article
Open access
PDF file
HCHyung Muk Choi
Hyung Muk Choi
SMSoo-youn Moon
Soo-youn Moon
HYHyung In Yang
Hyung In Yang
KKKyoung-Soo Kim
Kyoung-Soo Kim
Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has become a worldwide pandemic. Symptoms range from mild fever to cough, fatigue, severe pneumonia, acute respiratory distress syndrome (ARDS), and organ failure, with a mortality rate of 2.2%. However, there are no licensed drugs or definitive treatment strategies for patients with severe COVID-19. Only antiviral or anti-inflammatory drugs are used as symptomatic treatments based on clinician experience. Basic medical researchers are also trying to develop COVID-19 therapeutics. However, there is limited systematic information about the pathogenesis of COVID-19 symptoms that cause tissue damage or death and the mechanisms by which the virus infects and replicates in cells. Here, we introduce recent knowledge of time course changes in viral titers, delayed virus clearance, and persistent systemic inflammation in patients with severe COVID-19. Based on the concept of drug reposition, we review which antiviral or anti-inflammatory drugs can effectively treat COVID-19 patients based on progressive symptoms and the mechanisms inhibiting virus infection and replication.

3 March 2010 in Scandinavian Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
JLJeong-A Lee
Jeong-A Lee
CKCheol-In Kang
Cheol-In Kang
MJMi-Kyong Joung
Mi-Kyong Joung
SMSoo-youn Moon
Soo-youn Moon
DCDoo Ryeon Chung
Doo Ryeon Chung
JSJae-Hoon Song
Jae-Hoon Song

6 January 2012 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
SMSoo-youn Moon
Soo-youn Moon
DCDoo Ryeon Chung
Doo Ryeon Chung
SKShin-Woo Kim
Shin-Woo Kim
HCHyun-Ha Chang
Hyun-Ha Chang
HLHyuck Lee
Hyuck Lee
JSJae-Hoon Song
Jae-Hoon Song